Action Quantum Genomics - ALQGC

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,0722

Prix Achat

0,074

Prix Vente

0,06

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,001 Plage de 52 semaines 0,138

Cap du marché

5,033M

Clôture Veille

0,0722

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

0,00

Actions en circulation

69 709 954

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,54

Bénéfice par action (BPA)

-0,05

Chiffre d'affairess

36k

Bénéfice net

-3,17M

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

quantum-genomics.com/societe/

Siège social

Paris, Paris, Fra

Fondé

Quantum Genomics est coté dans le secteur Pharmaceutical Preparations de la Euronext avec le ticker ALQGC. Le dernier cours de clôture d'Quantum Genomics était de 0,07 €. Au cours de la dernière année, les actions de Quantum Genomics ont été négociées dans une fourchette de prix de 0,001 € à 0,138 €.

Quantum Genomics compte actuellement 69 709 954 actions en circulation. La capitalisation boursière d'Quantum Genomics est de 5,03 € million. Quantum Genomics a un ratio cours/bénéfice (ratio PE) de -1.54.

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in...

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.0001	0.138696255201	0.0721	0.0722	0.0721	0	0	DE
4	0.0001	0.138696255201	0.0721	0.0722	0.0721	0	0	DE
12	0.0001	0.138696255201	0.0721	0.0722	0.0721	0	0	DE
26	0.0001	0.138696255201	0.0721	0.0722	0.0721	0	0	DE
52	-0.0578	-44.4615384615	0.13	0.138	0.001	399137	0.0519481	DE
156	-1.9278	-96.39	2	4.32	0.001	300804	0.30945758	DE
260	-2.6478	-97.3455882353	2.72	6.185	0.001	291110	1.75912226	DE

ALQGC - Frequently Asked Questions (FAQ)

What is the current Quantum Genomics share price?

The current share price of Quantum Genomics is 0,0722 €

How many Quantum Genomics shares are in issue?

Quantum Genomics has 69 709 954 shares in issue

What is the market cap of Quantum Genomics?

The market capitalisation of Quantum Genomics is EUR 5,03M

What is the 1 year trading range for Quantum Genomics share price?

Quantum Genomics has traded in the range of 0,001 € to 0,138 € during the past year

What is the PE ratio of Quantum Genomics?

The price to earnings ratio of Quantum Genomics is -1,54

What is the cash to sales ratio of Quantum Genomics?

The cash to sales ratio of Quantum Genomics is 140

What is the reporting currency for Quantum Genomics?

Quantum Genomics reports financial results in EUR

What is the latest annual turnover for Quantum Genomics?

The latest annual turnover of Quantum Genomics is EUR 36k

What is the latest annual profit for Quantum Genomics?

The latest annual profit of Quantum Genomics is EUR -3,17M

What is the registered address of Quantum Genomics?

The registered address for Quantum Genomics is 6, RUE CAMBACERES, PARIS, PARIS, 75008

What is the Quantum Genomics website address?

The website address for Quantum Genomics is quantum-genomics.com/societe/

Which industry sector does Quantum Genomics operate in?

Quantum Genomics operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ALEXPOne Experience	1,28 € (56,10%)	1,76M
MLCOTCoretech 5	0,05 € (25,00%)	82,4k
MLGALGaleo Concept	1,69 € (21,58%)	40
ALKLKKerlink	0,82 € (20,59%)	151,49k
FCPFc Do Porto	1,10 € (19,57%)	28,02k
ALFLOFlorentaise SA	0,85 € (-61,19%)	1,13k
ALCBICrypto Blockchain Industries	0,47 € (-31,88%)	2,86M
ALBOOBOOSTHEAT	0,001 € (-28,57%)	7,47M
FPGUnion Tech Info	0,0656 € (-27,75%)	1,92k
ALTBGBlockchain GP	2,25 € (-25,99%)	11,37M
ALVERVergnet	0,0006 € (0,00%)	441,52M
ALCYBCybergun	0,0002 € (0,00%)	90,84M
BCPBanco Comercial Portugues SA	0,6426 € (1,13%)	82,26M
ALALOAcheterLouerFR	0,0004 € (0,00%)	64,04M
ALEUPEuroplasma	0,0083 € (-9,78%)	37,33M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Quantum Genomics (ALQGC)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Quantum Genomics

ALQGC Dernières nouvelles

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

Quantum Genomics announces the appointment of its new Scientific Advisory Board

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

ALQGC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Quantum Genomics (ALQGC) Cours

Quantum Genomics (ALQGC)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Quantum Genomics

ALQGC Dernières nouvelles

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

Quantum Genomics announces the appointment of its new Scientific Advisory Board

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

ALQGC - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Connectez-vous

Supprimer les publicités